Profile Image

Susmita Roy

Location iconKolkata
Beat iconPharma & Healthcare,
Profilealso seen in:Medical Dialogues,

Get in Touch with Susmita Roy

Contact Susmita Roy, search articles and posts on X, monitor coverage, and track replies from one place.

Learn More about the Skribe

Actions

Articles

Latest Articles by Susmita Roy

Kerala RCC Blacklists Globela Pharma After Brain Cancer Drug Found in Wrong Packaging

Kerala's RCC has blacklisted Globela Pharma after discovering that a brain cancer drug was packaged incorrectly, raising concerns ...Go to article

12/10/2025

CDSCO Orders Nationwide Audit of Cough Syrup Makers After Fatal Toxic Syrup Scare

The CDSCO has mandated a nationwide audit of cough syrup manufacturers following reports of toxic syrup linked to fatalities. This...Go to article

11/10/2025

Ongoing Sale of Covid-Era Liposomal Amphotericin B Challenged, SC Seeks Response from Top Pharma Firms, DCGI

The Supreme Court has requested responses from leading pharmaceutical companies regarding the ongoing sale of Liposomal Amphoteric...Go to article

11/10/2025

Delhi HC Dismisses Roche Appeal, Allows Natco to Continue Selling Generic Risdiplam for Spinal Muscular Atrophy

The Delhi High Court has dismissed Roche's appeal, allowing Natco to continue selling its generic version of Risdiplam, a treatmen...Go to article

11/10/2025

CDSCO Panel seeks clarifications from Novo Nordisk on IcoSema phase IIIb clinical study protocol

The CDSCO Panel has requested clarifications from Novo Nordisk regarding the clinical study protocol for IcoSema, a phase IIIb tri...Go to article

11/10/2025

No Entry Without Notice CDSCO Directs All Drug Shipments Through Notified Ports via ICEGATE

The CDSCO has mandated that all drug shipments must go through notified ports via ICEGATE, ensuring better regulation and tracking...Go to article

10/10/2025

Fludrocortisone 0.2 mg Study Rejected by CDSCO Panel Over Potential Adverse Effects

The CDSCO panel has rejected the study of Fludrocortisone 0.2 mg due to concerns over potential adverse effects, raising questions...Go to article

09/10/2025

Unequal Trials in New Drug Approvals CDSCO Seeks Feedback for Policy Reform

The CDSCO is seeking feedback on policy reforms regarding new drug approvals, highlighting the disparities in trial processes and ...Go to article

09/10/2025

Exemed Pharma's Empagliflozin-Vildagliptin Combo Rejected by CDSCO Panel Over Questionable Clinical Use

The CDSCO panel has rejected Exemed Pharma's combination drug Empagliflozin-Vildagliptin due to concerns regarding its clinical us...Go to article

08/10/2025

Ravenbhel Gets SEC Nod to Market Bilastine, Montelukast FDC, Phase IV Trial Mandated

Ravenbhel has received approval from the SEC to market Bilastine and Montelukast FDC, with a Phase IV trial mandated for further e...Go to article

08/10/2025